Hexarelin: uses, dosing & the facts
A potent growth hormone releasing peptide, more powerful than other GHRPs. Provides strong growth hormone and IGF-1 stimulation. This is an evidence-graded reference — what it is, what it's used for, typical reported dosing, half-life, side effects, and how to track it. It is educational, not medical advice or a recommendation to use a research compound.
- • Hexarelin — GHRP · GH secretagogue. A potent growth hormone releasing peptide, more powerful than other GHRPs.
- • Commonly used for powerful growth hormone release, muscle growth and recovery, fat loss.
- • Half-life: Approximately 20-30 minutes.
- • Status: Research use only · not FDA-approved — an educational reference, not a dose protocol or sourcing advice.
What Hexarelin is
A potent growth hormone releasing peptide, more powerful than other GHRPs. Provides strong growth hormone and IGF-1 stimulation.
What Hexarelin is used for
- • Powerful growth hormone release
- • Muscle growth and recovery
- • Fat loss
- • Enhanced athletic performance
- • Strong IGF-1 elevation
- • Body recomposition
These are reported/community uses, not proven clinical outcomes. Most research peptides have limited human trial data behind such claims.
Typical reported dosing
| Injectable | 100-200mcg injected subcutaneously 1-2x daily on empty stomach |
Presented as commonly-reported patterns for information only — not a dose recommendation. Hexarelin dosing is a decision for a qualified clinician.
Reconstitution
Reconstitute with bacteriostatic water. The arithmetic is the same for any peptide: concentration = vial mg ÷ water mL, and on a U-100 syringe 100 units = 1 mL. Compute your own vial with the reconstitution calculator.
Half-life & cycling
Half-life: Approximately 20-30 minutes. Half-life drives dosing frequency and how quickly the compound clears — see it plotted on the half-life visualizer.
Cycling
Typical cycles: 8-12 weeks on, 4 weeks off. More potent than other GHRPs.
Side effects & warnings
- • Stronger effects than other GHRPs
- • Possible desensitization with prolonged use
- • Water retention possible
- • Some report mild hunger increase
More potent than other GHRPs. May cause quicker receptor desensitization. Cycle off regularly. Monitor for tolerance. Take on empty stomach for best results.
Tracking Hexarelin in OptiPin
If you're tracking a Hexarelin protocol, OptiPin logs each dose with reminders and site rotation, charts the outcome you care about over your dose timeline, keeps per-vial inventory with runout warnings, and (where relevant) does the reconstitution math — all on-device, no account.
Log doses, outcomes & vials in OptiPin
Reminders, outcome-over-dose charts, vial runout warnings, and built-in reconstitution math — all on-device.
Download on the App StoreFAQ
What is Hexarelin?
A potent growth hormone releasing peptide, more powerful than other GHRPs. Provides strong growth hormone and IGF-1 stimulation.
What is Hexarelin used for?
Commonly discussed uses include: powerful growth hormone release, muscle growth and recovery, fat loss, enhanced athletic performance, strong igf-1 elevation, body recomposition. These are reported uses, not proven outcomes or a recommendation.
How is Hexarelin dosed?
Commonly reported dosing: Injectable — 100-200mcg injected subcutaneously 1-2x daily on empty stomach. This reflects patterns discussed in the community and is presented for information only, not as a dose recommendation — Hexarelin is not an approved medicine and dosing should involve a qualified clinician.
How do you reconstitute Hexarelin?
Reconstitute with bacteriostatic water. On a U-100 syringe, 100 units = 1 mL. Concentrations vary by vial, so compute from your own vial with a reconstitution calculator.
What is Hexarelin's half-life?
Approximately 20-30 minutes. Half-life shapes how often it is dosed and how quickly it clears.
What are Hexarelin's side effects?
Reported effects include: stronger effects than other ghrps, possible desensitization with prolonged use, water retention possible, some report mild hunger increase. Because it is a research compound, its safety profile is not fully characterized; discuss risks with a clinician.
Evidence & further reading
- Search the peer-reviewed literature for Hexarelin on PubMed (entry point to the primary evidence base, not a specific citation).
- Hexarelin on ClinicalTrials.gov — registered human trials, if any.
- US FDA / 503A compounding status of research peptides (2026).
- OptiPin peptides guide — categories, evidence grading, and how to run a protocol honestly.
Related
IGF-1 LR3 · Ipamorelin · MK-777 (Acetamoren) · Sermorelin · BPC-157 · TB-500 · Reconstitution calculator · All peptides